Reader View AI Reader View Zymeworks EVP, head of R&D Adam Schayowitz sells $357,557 in stock. www.investing.com · October 9, 2026 · 23:01 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link